AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimpo, K.
Right arrow Articles by Fujita, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimpo, K.
Right arrow Articles by Fujita, K.
Agricola
Right arrow Articles by Shimpo, K.
Right arrow Articles by Fujita, K.

American Journal of Clinical Nutrition, Vol 54, 1298S-1301S, Copyright © 1991 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Ascorbic acid and adriamycin toxicity

K Shimpo, T Nagatsu, K Yamada, T Sato, H Niimi, M Shamoto, T Takeuchi, H Umezawa and K Fujita
Institute for Comprehensive Medical Science, School of Medicine, Fujita Health University, Aichi, Japan.

Adriamycin (ADR) is effective against a wide range of human neoplasms. However, its clinical use is compromised by serious cardiac toxicity, possibly through induction of peroxidation in cardiac lipids. Ascorbic acid, a potent antioxidant, was examined for effect in reducing ADR toxicity in mice and guinea pigs. Ascorbic acid had no effect on the antitumor activity of ADR in mice inoculated with leukemia L1210 or Ehrlich ascites carcinoma, but it significantly prolonged the life of animals treated with ADR. ADR elevated lipid peroxide levels in mouse heart, and ascorbic acid prevented the elevation. The significant prevention of ADR-induced cardiomyopathy in guinea pigs by ascorbic acid was proved by electron microscopy. Ascorbic acid and the derivatives may delay general toxicity of ADR and also prevent the cardiac toxicity. The results also suggest the clinical efficacy of the combined treatment of ADR and ascorbic acid or the derivatives.


This article has been cited by other articles:


Home page
 Integr Cancer TherHome page
K. A. Conklin
Coenzyme Q10 for Prevention of Anthracycline-Induced Cardiotoxicity
Integr Cancer Ther, June 1, 2005; 4(2): 110 - 130.
[Abstract] [PDF]

Home page
 Integr Cancer TherHome page
M. Gaynor
One Oncologist's View of Integrative Care: Keynote Address, Comprehensive Cancer Care Conference, April 2003
Integr Cancer Ther, March 1, 2004; 3(1): 82 - 87.
[PDF]

Home page
 J. Nutr.Home page
E. Rock and A. DeMichele
Nutritional Approaches to Late Toxicities of Adjuvant Chemotherapy in Breast Cancer Survivors
J. Nutr., November 1, 2003; 133(11): 3785S - 3793.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
N G Fisher and A J Marshall
Management options: Anthracycline-induced cardiomyopathy
Postgrad. Med. J., May 1, 1999; 75(883): 265 - 268.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The American Society for Nutrition